摘要
目的:探讨新生儿高胆红素血症对凝血功能的影响及其临床意义。方法:选取2013年1-6月于笔者所在医院出生的168例新生儿的凝血结果进行回顾性分析。将临床上诊断为新生儿高胆红素血症的108例新生儿设为研究组,包括新生儿病理性高胆红素血症组18例和生理性高胆红素血症组90例,将同期出生的60例正常足月儿设为对照组。对三组患儿的凝血结果进行统计分析。结果:病理性高胆红素血症组PT、APTT明显高于生理性高胆红素血症组,且两组明显高于对照组,差异有统计学意义(P<0.05)。结论:新生儿高胆红素血症可影响新生儿的凝血功能,临床上诊断及治疗新生儿出血性疾病的疗效时应排除高胆红素血症的影响。
Objective：To investigate neonatal hyperbilirubinemia on coagulation function and clinical significance.Method：Selection in the author＆#39;s hospital between January and June 2013 was born in 168 cases of neonatal blood coagulation results were retrospectively analyzed. Will be clinically diagnosed as high neonatal bilirubin of 108 newborns is set to the team,including a newborn pathological high bilirubin blood disease group 18 cases and physiologic high bilirubin group 90 examples,will be born in the same period of 60 cases of normal full term set as control group. The coagulation results of three groups of children were analyzed.Result：The results of pathologic hyperbilirubinemia group PT,APTT was significantly higher than physiological hyperbilirubinemia group,and significantly higher in both groups,the difference was statistically significant （P〈0.05）. Conclusion：Neonatal hyperbilirubinemia can affect coagulation newborn, the clinical diagnosis and treatment of newborns should efficacy exclude bleeding disorders affect hyperbilirubinemia.
出处
《中外医学研究》
2014年第11期51-52,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
